{Reference Type}: Journal Article
{Title}: Using Molecular Targets to Predict and Treat Aortic Aneurysms.
{Author}: Zhou X;Liu G;Lai H;Wang C;Li J;Zhu K;
{Journal}: Rev Cardiovasc Med
{Volume}: 23
{Issue}: 9
{Year}: 2022 Sep
{Factor}: 4.43
{DOI}: 10.31083/j.rcm2309307
{Abstract}: Aortic aneurysms are life-threatening vascular diseases associated with high morbidity, and usually require prophylactic surgical intervention. Current preventative management of aortic aneurysms relies on the diameter and other anatomic parameters of the aorta, but these have been demonstrated to be insufficient predictive factors of disease progression and potential complications. Studies on pathophysiology of aortic aneurysms could fill this need, which already indicated the significance of specific molecules in aortic aneurysms. These molecules provide more accurate prediction, and they also serve as therapeutic targets, some of which are in preclinical stage. In this review, we summarized the inadequacies and achievements of current clinical prediction standards, discussed the molecular targets in prediction and treatment, and especially emphasized the molecules that have shown potentials in early diagnosis, accurate risk assessment and target treatment of aortic aneurysm at early stage.